Replies to post #5726 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

Yeah...Array Biopharma is another heavyweight.

Their Cancer pipeline might be worth 10 times the buyout price over the life of all their drug patents.

However, what's eye popping is it's an ALL CASH deal!

Transaction valued at $48 per Array share in cash, for a total enterprise value of approximately $11.4 billion

www.businesswire.com/news/home/20190617005373/en/Pfizer-Acquire-Array-BioPharma

Lot's of money out there to change hands in BIG PHARMA LAND.

Good $-tuff $-moki

Peace,

/////AMG